BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21079245)

  • 1. PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
    Ryu H; Furuta M; Kirkpatrick D; Gygi SP; Azuma Y
    J Cell Biol; 2010 Nov; 191(4):783-94. PubMed ID: 21079245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin.
    Ryu H; Yoshida MM; Sridharan V; Kumagai A; Dunphy WG; Dasso M; Azuma Y
    Cell Cycle; 2015; 14(17):2777-84. PubMed ID: 26131587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
    Ryu H; Azuma Y
    J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
    Li H; Wang Y; Liu X
    J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
    Dawlaty MM; Malureanu L; Jeganathan KB; Kao E; Sustmann C; Tahk S; Shuai K; Grosschedl R; van Deursen JM
    Cell; 2008 Apr; 133(1):103-15. PubMed ID: 18394993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
    Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
    Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
    Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
    J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of SUMOylation of topoisomerase IIalpha with Xenopus egg extracts.
    Azuma Y
    Methods Mol Biol; 2009; 582():221-31. PubMed ID: 19763953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase.
    Rouzeau S; Cordelières FP; Buhagiar-Labarchède G; Hurbain I; Onclercq-Delic R; Gemble S; Magnaghi-Jaulin L; Jaulin C; Amor-Guéret M
    PLoS One; 2012; 7(4):e33905. PubMed ID: 22563370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis.
    Yoshida MM; Ting L; Gygi SP; Azuma Y
    J Cell Biol; 2016 Jun; 213(6):665-78. PubMed ID: 27325792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
    Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
    Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PICH regulates the abundance and localization of SUMOylated proteins on mitotic chromosomes.
    Hassebroek VA; Park H; Pandey N; Lerbakken BT; Aksenova V; Arnaoutov A; Dasso M; Azuma Y
    Mol Biol Cell; 2020 Nov; 31(23):2537-2556. PubMed ID: 32877270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line.
    Carpenter AJ; Porter AC
    Mol Biol Cell; 2004 Dec; 15(12):5700-11. PubMed ID: 15456904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
    Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
    Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
    Azuma Y; Arnaoutov A; Anan T; Dasso M
    EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
    Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
    Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.